Načítá se...
Beefing up Prostate Cancer Therapy with Performance-Enhancing (Anti-) Steroids
In the May 26th issue of the New England Journal of Medicine, de Bono et al. report that the inhibition of androgen synthesis by abiraterone acetate prolonged the survival of men with prostate cancer previously treated by androgen suppression.
Uloženo v:
| Vydáno v: | Cancer Cell |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4479125/ https://ncbi.nlm.nih.gov/pubmed/21741594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2011.06.019 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|